These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 4147609)

  • 21. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 22. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
    Olowoyeye JO; Thadani U; Parker JO
    Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic effects of beta-adrenergic blockade.
    Aström H
    Br Heart J; 1968 Jan; 30(1):44-9. PubMed ID: 5637556
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
    Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H
    Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta adrenergic receptor blockaders in treatment of angina pectoris. A critical evaluation].
    Lukasik S; Wrabec K; Stańkowska K; Janicka K
    Pol Tyg Lek; 1973 Jan; 28(1):17-20. PubMed ID: 4405580
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of inderal and trasicor on the function of external respiration in chronic coronary insufficiency].
    Liutoev GI; Ermilov LP
    Kardiologiia; 1973 Oct; 13(10):96-103. PubMed ID: 4150015
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of anaprilin on hemodynamics and cardiac rhythm].
    Zharko KP
    Vrach Delo; 1971 Jul; 7():33-6. PubMed ID: 4399348
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of adrenergic beta-receptor antagonists in angina pectoris.
    Thadani U; Sharma B; Meeran MK; Majid PA; Whitaker W; Taylor SH
    Br Med J; 1973 Jan; 1(5846):138-42. PubMed ID: 4145234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic actions of nitrite-beta-adrenergic blocking agents in the therapy of angina pectoris. Pharmacologic and therapeutic rationale.
    Klein HO; Berger HJ
    Cardiology; 1973; 58(6):313-25. PubMed ID: 4153989
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-adrenoceptor-blocking agents in the management of hypertension.
    Prichard BN
    Cardiology; 1979; 64 Suppl 1():44-87. PubMed ID: 42488
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia].
    Zaĭtseva VI; Sharaeva ML
    Vrach Delo; 1988 Dec; (12):15-8. PubMed ID: 2907700
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies with long acting propranolol.
    Shanks RG
    Postgrad Med J; 1984; 60 Suppl 2():61-8. PubMed ID: 6463010
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
    Goch JH
    Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Beta-adrenoceptor blockade and coronary artery surgery.
    Oka Y; Frishman W; Becker RM; Kadish A; Strom J; Matsumoto M; Orkin L; Frater R
    Am Heart J; 1980 Feb; 99(2):255-69. PubMed ID: 6101516
    [No Abstract]   [Full Text] [Related]  

  • 40. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
    Franciosa JA; Johnson SM; Tobian LJ
    Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.